Agrochemical company India Pesticides on Friday said it has fixed a price band of Rs 290-296 a share for its Rs 800-crore initial share sale. The three-day initial public offer (IPO) will open on June 23 and conclude on June 25. The bidding for anchor investors will open on June 22, according to the company. The Rs 800-crore IPO comprises fresh issuance of equity shares amounting to Rs 100 crore and an offer of sale for equity shares aggregating up to Rs 281.4 crore by promoter Anand Swarup Agarwal and up to Rs 418.6 crore by other selling shareholders. The Uttar Pradesh-based company may decide to undertake a pre-IPO placement of Rs 75 crore subject to consultation of the merchant bankers. Proceeds of the fresh issue would be used towards funding the working capital requirements and general corporate purposes. India Pesticides is an R&D focused agrochemical technical company, which has growing formulations business in herbicides, insecticides and fungicide segments. It also ...
Healthy demand, focus on cost optimisation and expansion plans drive optimism
Healthy fundamentals and expectation of a strong second half of 2020-21 cheer investors
Agrochemicals manufacturer UPL has completed the pre-payment of $410 million of 3.25 per cent senior notes due in October 2021
The govt asked the agro-chemicals industry to come out with new molecules of global standards for farmers' benefit, while an industry body pitched for stable policy, regulations to boost the sector
Sources in the know said the Centre was also looking at increasing Customs duty on formulations, agrochemicals, and pesticides falling under different Harmonized System of Nomenclature codes
In the past one month, Dhanuka Agritech, Sharda Cropchem, Aster Lifesciences, Bayer Cropscience, Insecticides India, Rallis India and UPL have rallied between 11 per cent and 44 per cent
Moody's assigns Baa3 rating, says outlook stable for agrochemical company.
Govt should review its proposal on agro-chem products
UPL, Rallis India and Sumitomo Chemical India were up 5 per cent each on the BSE.
Analysts say, chemicals being considered for ban form significant part of the portfolio, both exports and domestic sales, of many players
Net impact would depend on final list of chemicals to be banned and companies' move to diversify portfolio
CRISIL says India will continue to see more of licensing collaborations and distribution tie-ups
With several products going off-patent globally, Indian firms can leverage opportunities for generics, contract manufacturing & research, says a report of Tata Strategic Management and FICCI
While Metahelix will hold 49 percent stake in the JV firm PT Metahelix Lifesciences Indonesia, the remaining will be with its local partner, Suresh Gobindram Vaswani
Monsanto India, Atul, Sharda Cropchem, Rallis India and Bayer CropScience were up 3%-18% on the BSE.